vs
BALCHEM CORP（BCPC）与医疗房产信托（SVC）财务数据对比。点击上方公司名可切换其他公司
医疗房产信托的季度营收约是BALCHEM CORP的1.1倍（$296.5M vs $270.7M），BALCHEM CORP净利率更高（14.9% vs -0.3%，领先15.1%），BALCHEM CORP同比增速更快（8.1% vs -17.0%），BALCHEM CORP自由现金流更多（$33.8M vs $-95.2M），过去两年BALCHEM CORP的营收复合增速更高（7.5% vs -6.1%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
医疗房产信托（MPT）是总部位于阿拉巴马州伯明翰的国际房地产投资信托（REIT），主要在美国和欧洲地区收购投资医疗设施与营利性医疗控股公司。该公司的房产收购多采用售后回租模式，原产权方出售房产给MPT后成为承租租户，其租户普遍签订长期三净租约。
BCPC vs SVC — 直观对比
营收规模更大
SVC
是对方的1.1倍
$270.7M
营收增速更快
BCPC
高出25.0%
-17.0%
净利率更高
BCPC
高出15.1%
-0.3%
自由现金流更多
BCPC
多$129.0M
$-95.2M
两年增速更快
BCPC
近两年复合增速
-6.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.7M | $296.5M |
| 净利润 | $40.3M | $-782.0K |
| 毛利率 | — | — |
| 营业利润率 | 20.5% | -3.9% |
| 净利率 | 14.9% | -0.3% |
| 营收同比 | 8.1% | -17.0% |
| 净利润同比 | 8.7% | 99.0% |
| 每股收益（稀释后） | $1.25 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCSVC
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $296.5M | ||
| Q3 25 | $267.6M | $377.6M | ||
| Q2 25 | $255.5M | $404.4M | ||
| Q1 25 | $250.5M | $335.0M | ||
| Q4 24 | $240.0M | $357.0M | ||
| Q3 24 | $239.9M | $390.9M | ||
| Q2 24 | $234.1M | $412.5M |
净利润BCPCSVC
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $-782.0K | ||
| Q3 25 | $40.3M | $-46.9M | ||
| Q2 25 | $38.3M | $-38.2M | ||
| Q1 25 | $37.1M | $-116.4M | ||
| Q4 24 | $33.6M | $-76.4M | ||
| Q3 24 | $33.8M | $-46.9M | ||
| Q2 24 | $32.1M | $-73.8M |
毛利率BCPCSVC
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
营业利润率BCPCSVC
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | -3.9% | ||
| Q3 25 | 20.4% | -12.8% | ||
| Q2 25 | 20.1% | -9.2% | ||
| Q1 25 | 20.4% | -33.3% | ||
| Q4 24 | 19.8% | -19.4% | ||
| Q3 24 | 20.0% | -12.8% | ||
| Q2 24 | 19.6% | -17.1% |
净利率BCPCSVC
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | -0.3% | ||
| Q3 25 | 15.1% | -12.4% | ||
| Q2 25 | 15.0% | -9.4% | ||
| Q1 25 | 14.8% | -34.8% | ||
| Q4 24 | 14.0% | -21.4% | ||
| Q3 24 | 14.1% | -12.0% | ||
| Q2 24 | 13.7% | -17.9% |
每股收益（稀释后）BCPCSVC
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $-0.01 | ||
| Q3 25 | $1.24 | $-0.28 | ||
| Q2 25 | $1.17 | $-0.23 | ||
| Q1 25 | $1.13 | $-0.70 | ||
| Q4 24 | $1.03 | $-0.46 | ||
| Q3 24 | $1.03 | $-0.28 | ||
| Q2 24 | $0.98 | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $346.8M |
| 总债务越低越好 | — | $5.5B |
| 股东权益账面价值 | $1.3B | $646.1M |
| 总资产 | $1.7B | $6.5B |
| 负债/权益比越低杠杆越低 | — | 8.52× |
8季度趋势，按日历期对齐
现金及短期投资BCPCSVC
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $346.8M | ||
| Q3 25 | $65.1M | $417.4M | ||
| Q2 25 | $65.4M | $63.2M | ||
| Q1 25 | $49.9M | $80.1M | ||
| Q4 24 | $49.5M | $143.5M | ||
| Q3 24 | $73.7M | $48.6M | ||
| Q2 24 | $63.7M | $14.6M |
总债务BCPCSVC
| Q1 26 | — | — | ||
| Q4 25 | — | $5.5B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $5.8B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益BCPCSVC
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $646.1M | ||
| Q3 25 | $1.3B | $647.9M | ||
| Q2 25 | $1.3B | $695.9M | ||
| Q1 25 | $1.2B | $734.6M | ||
| Q4 24 | $1.1B | $851.9M | ||
| Q3 24 | $1.2B | $929.0M | ||
| Q2 24 | $1.1B | $1.0B |
总资产BCPCSVC
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $6.5B | ||
| Q3 25 | $1.7B | $7.0B | ||
| Q2 25 | $1.7B | $6.9B | ||
| Q1 25 | $1.6B | $7.0B | ||
| Q4 24 | $1.6B | $7.1B | ||
| Q3 24 | $1.6B | $7.1B | ||
| Q2 24 | $1.6B | $7.1B |
负债/权益比BCPCSVC
| Q1 26 | — | — | ||
| Q4 25 | — | 8.52× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.85× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $40.1M | $-18.5M |
| 自由现金流经营现金流 - 资本支出 | $33.8M | $-95.2M |
| 自由现金流率自由现金流/营收 | 12.5% | -32.1% |
| 资本支出强度资本支出/营收 | 2.3% | 25.9% |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $-107.0M |
8季度趋势，按日历期对齐
经营现金流BCPCSVC
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $-18.5M | ||
| Q3 25 | $65.6M | $98.1M | ||
| Q2 25 | $47.3M | $-7.0K | ||
| Q1 25 | $36.5M | $38.2M | ||
| Q4 24 | $52.3M | $-9.7M | ||
| Q3 24 | $51.3M | $106.2M | ||
| Q2 24 | $45.0M | $43.8M |
自由现金流BCPCSVC
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $-95.2M | ||
| Q3 25 | — | $57.9M | ||
| Q2 25 | — | $-46.6M | ||
| Q1 25 | — | $-23.2M | ||
| Q4 24 | — | $-88.9M | ||
| Q3 24 | — | $24.1M | ||
| Q2 24 | — | $-22.3M |
自由现金流率BCPCSVC
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | -32.1% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | -11.5% | ||
| Q1 25 | — | -6.9% | ||
| Q4 24 | — | -24.9% | ||
| Q3 24 | — | 6.2% | ||
| Q2 24 | — | -5.4% |
资本支出强度BCPCSVC
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 25.9% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 11.5% | ||
| Q1 25 | — | 18.3% | ||
| Q4 24 | — | 22.2% | ||
| Q3 24 | — | 21.0% | ||
| Q2 24 | — | 16.0% |
现金转化率BCPCSVC
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
